A mother who is a carrier of the hepatitis B virus asks whether the sequence of her child’s hepatitis B vaccine administration will affect the effectiveness of maternal-infant transmission blockade.

Discuss how to prevent hepatitis B transmission from mother to child through vaccination and cell therapy.

A carrier of HBV with a ’ surface antigen+ ’ status inquires about the impact of different vaccination schedules on the effectiveness of maternal-infant transmission blockade.